Ekso bionics to present at h.c. wainwright 24th annual global investment conference

San rafael, calif., sept. 06, 2022 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that scott davis, president and chief operating officer, will be presenting virtually at the h.c. wainwright 24th annual global investment conference taking place september 12-14, 2022.
EKSO Ratings Summary
EKSO Quant Ranking